There will be a ‘before’ and ‘after’ of the pandemic crisis and it is easy to imagine that the new world will force a rethink of the rules of the game

From marijuana to medication procurement, there are many pending issues that need to be clarified from a regulatory point of view.

Zacatecas is primarily known for its strong mining industry. Can it become a significant player in technology innovation?

In the most recent WTO report, Mexico was ranked fifth among the main exporters of critical medical products to combat COVID-19 in 2020.

Michel Yehuda discusses the company’s technological expertise in various sectors, including support for CFE’s transmission and distribution.

Industries that invest for a long period of time in operations gain a huge benefit by focusing on total cost, including purchasing and operation.

IMPI provides a new dynamic for the pharma industry with the expectation that industrial property is used as a tool for growth and not as a barrier.

What do changes to the regulatory framework represent, and what consequences can be expected?

Annual economic loss due to depression and anxiety is almost US$1 trillion but investing on treatment generates a return of $5 for every dollar spent